Light
Dark
Expandable Search
Light
Dark

YOUR AD GOES HERE

Clinical Trials, Startups

12 Sep 2025

Early Alzheimer’s Egg-Shell Protein Therapy Shows Promise in Small Human Study

A phase 1 pilot trial suggests that a novel egg-shell derived peptide may reduce Alzheimer’s biomarkers and improve memory in mild Alzheimer’s patients
featured

Leaders, Startups

8 Aug 2025

New Zealand beat Australian Champions #2

New Zealand's women beat newly-crowned world sevens series champions Australia 21-14 in the final leg in Toulouse.

Clinical Trials, FDA Approvals

15 Jul 2025

Ultragenyx Gene Therapy Rejected by FDA Even as Takeda Scores Big in Narcolepsy Trial

One company faces regulatory setback while another achieves a Phase III victory, highlighting both urgency and uncertainty in drug development

Breaking News, FDA Approvals

14 Jul 2025

FDA Rejects UltraGeneX’s Gene Therapy Application, Pivotal Phase III Reads Out for Takeda Narcolepsy Drug

Regulatory setback for one biotech contrasts with a major success in sleep disorder treatment, underscoring the high stakes in clinical development

Biopharma Highlights, Partnerships

13 Jul 2025

CSL Enters Major Partnership with VarmX to Advance Bleeding Management Drug

A new collaboration aims to develop VMX-C001 to treat severe bleeding in patients on anticoagulants, targeting a 2029 launch

Breaking News, Breakthroughs, Innovation, Top Stories

11 Jul 2025

New Phase 1/2 Study Shows Promise for Oral Alzheimer’s Drug in Early Alzheimer’s Disease

Early results from a multi-centre trial indicate that BI-8721 may slow cognitive decline and reduce amyloid biomarkers in people with mild Alzheimer’s

Investments, Venture Capital

10 Jul 2025

Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress

Interim data in osteogenesis imperfecta show safety remains acceptable, but efficacy thresholds for early stopping were not met

Breaking News, Top Stories

9 Jul 2025

New Regulatory Shift: NIH Requires Alternatives to Animal-Only Studies in Funded Research

Major change in NIH policy mandates inclusion of organoids, computational models, or other non-animal methods in proposals, likely transforming preclinical research paradigms

Biopharma Highlights

8 Jul 2025

Strong Real-World Data Strengthens Case for Long-Acting HIV Injectables

ViiV Healthcare shows long-acting regimens may improve convenience, adherence, and satisfaction for people living with HIV